ZyVersa Therapeutics, Inc.
ZVSA· OTC
Quarterly figures for ZyVersa Therapeutics, Inc., with source filings when available.
19 quarters. Jun 30, 2021 to Mar 31, 2026. mixed units.
ZyVersa Therapeutics, Inc. has filed its 10-Q within 40 to 50 days of period end across its last 8 quarters. The 10-K runs 85 to 109 days.
ZyVersa Therapeutics, Inc. · CIK 1859007 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q1 2026 | Mar 31, 2026 | — | May 13, 2026 | 43 d | 10-Q | — | — | -$0.22 | |
| FY 2025 | |||||||||
| Q4 2025derived | Dec 31, 2025 | — | Mar 31, 2026 | 90 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | Nov 19, 2025 · after-hours | Nov 19, 2025 | 50 d | 10-Q | ||||
| FY 2024 | |||||||||
| Q4 2024derived | Dec 31, 2024 | — | Mar 27, 2025 | 86 d | 10-K | — | — | — | |
| Q3 2024 | Sep 30, 2024 | Nov 14, 2024 · pre-market | Nov 14, 2024 | 45 d | 10-Q | ||||
| FY 2023 | |||||||||
| Q4 2023derived | Dec 31, 2023 | — | Mar 25, 2024 | 85 d | 10-K | — | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 14, 2023 | 45 d | 10-Q | ||||
| FY 2022 | |||||||||
| Q4 2022derived | Dec 12, 2022 | — | Mar 31, 2023 | 109 d | 10-K | — | — | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | ||||
| FY 2021 | |||||||||
| Q3 2021 | Sep 30, 2021 | — | — | — | — | — | — | — | |
| Q2 2021 | Jun 30, 2021 | — | — | — | — | — | — | — | |
| — |
| — |
| -$2.56 |
| Q2 2025 | Jun 30, 2025 | — | Aug 13, 2025 | 44 d | 10-Q | — | — | -$0.46 |
|---|
| Q1 2025 | Mar 31, 2025 | — | May 12, 2025 | 42 d | 10-Q | — | — | -$0.73 |
|---|
| — |
| — |
| -$2.43 |
| Q2 2024 | Jun 30, 2024 | — | Aug 9, 2024 | 40 d | 10-Q | — | — | -$3.31 |
|---|
| Q1 2024 | Mar 31, 2024 | — | May 15, 2024 | 45 d | 10-Q | — | — | -$4.53 |
|---|
| — |
| — |
| -$30.18 |
| Q2 2023 | Jun 30, 2023 | — | Aug 21, 2023 | 52 d | 10-Q | — | — | -$1,694.12 |
|---|
| Q1 2023 | Mar 31, 2023 | May 12, 2023 · after-hours | May 12, 2023 | 42 d | 10-Q | — | — | -$135.88 |
|---|
| — |
| — |
| — |
| Q2 2022 | Jun 30, 2022 | — | Aug 15, 2022 | 46 d | 10-Q | — | — | — |
|---|
| Q1 2022 | Mar 31, 2022 | — | May 13, 2022 | 43 d | 10-Q | — | — | — |
|---|